Global Biochips Market by Type (Arrays, DNA Chips, Lab-On-A-Chip), Fabrication Technology (Microarrays, Microfluidics), Application, End-User - Cumulative Impact of High Inflation - Forecast 2023-2030- Product Image

Sale

Global Biochips Market by Type (Arrays, DNA Chips, Lab-On-A-Chip), Fabrication Technology (Microarrays, Microfluidics), Application, End-User - Cumulative Impact of High Inflation - Forecast 2023-2030

Report
233 Pages
May 2023
Region: Global
360iResearch™
ID: 4857855

UP TO €864EUR$895USD£744GBP OFF until Jun 30^th 2023

The Global Biochips Market size was estimated at USD 44.13 billion in 2022, USD 53.42 billion in 2023, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 21.18% to reach USD 205.30 billion by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Biochips Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Biochips Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Type, market is studied across Arrays, DNA Chips, Lab-On-A-Chip, and Protein Chips. The Arrays is further studied across Cell Arrays and Tissue Arrays. The Arrays is projected to witness significant market share during forecast period.
Based on Fabrication Technology, market is studied across Microarrays and Microfluidics. The Microfluidics is projected to witness significant market share during forecast period.
Based on Application, market is studied across Agricultural Biotechnology, Cancer Diagnosis & Treatment, Clinical Diagnostics, Diagnostics, DNA Chip Applications, Drug Discovery, Expression Profiling, Gene Expression, Genomics, High-Throughput Screening, IVD & POC, Proteomics, and SNP Genotyping. The Expression Profiling is projected to witness significant market share during forecast period.
Based on End-User, market is studied across Academic & Research Institutes, Biotechnology & Pharmaceutical Companies, and Hospitals & Diagnostics Centers. The Biotechnology & Pharmaceutical Companies is projected to witness significant market share during forecast period.
Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Biochips Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Biochips Market, including Abbott Laboratories, Agilent Technologies, Inc., AYOXXA Biosystems GmbH, Bio-Rad Laboratories, Inc., Cellix Ltd., Diagnostic Biochips, F. Hoffmann-La Roche Ltd., GE Healthcare, Illumina, Inc., Innovative Biochips, Luminex Corporation by DiaSorin S.p.A., Merck KGaA, PerkinElmer Inc., Sphere Fluidics Limited, and Thermo Fisher Scientific Inc.

The report provides insights on the following pointers:

Market Penetration: Provides comprehensive information on the market offered by the key players
Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation
Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

What is the market size and forecast of the Global Biochips Market?
What are the inhibiting factors and impact of COVID-19 shaping the Global Biochips Market during the forecast period?
Which are the products/segments/applications/areas to invest in over the forecast period in the Global Biochips Market?
What is the competitive strategic window for opportunities in the Global Biochips Market?
What are the technology trends and regulatory frameworks in the Global Biochips Market?
What is the market share of the leading vendors in the Global Biochips Market?
What modes and strategic moves are considered suitable for entering the Global Biochips Market?

Frequently Asked Questions about the Global Biochips Market

What is the estimated value of the Global Biochips Market?

The Global Biochips Market was estimated to be valued at $44.13 Billion in 2022.

What is the growth rate of the Global Biochips Market?

The growth rate of the Global Biochips Market is 21.1%, with an estimated value of $205.3 Billion by 2030.

What is the forecasted size of the Global Biochips Market?

The Global Biochips Market is estimated to be worth $205.3 Billion by 2030.

Who are the key companies in the Global Biochips Market?

Key companies in the Global Biochips Market include Abbott Laboratories, Agilent Technologies, Inc., AYOXXA Biosystems GmbH, Bio, Rad Laboratories, Inc., Cellix Ltd., Diagnostic Biochips, F. Hoffmann, La Roche Ltd. and GE Healthcare.

Report Attribute	Details
No. of Pages	233
Published	May 2023
Forecast Period	2022 - 2030
Estimated Market Value ( USD ) in 2022	$ 44.13 Billion
Forecasted Market Value ( USD ) by 2030	$ 205.3 Billion
Compound Annual Growth Rate	21.1%
Regions Covered	Global
No. of Companies Mentioned	15

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Biochips Market, by Type, 2022 vs 2030
4.3. Biochips Market, by Fabrication Technology, 2022 vs 2030
4.4. Biochips Market, by Application, 2022 vs 2030
4.5. Biochips Market, by End-User, 2022 vs 2030
4.6. Biochips Market, by Region, 2022 vs 2030

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing incidences of life-threatening disorder and rise in geriatric population
5.1.1.2. Demand of personalized adoption owing to increase adoption
5.1.1.3. Large number of biochips applications
5.1.2. Restraints
5.1.2.1. Loosely defined regulatory guidelines
5.1.3. Opportunities
5.1.3.1. Potential in untapped developed regions
5.1.3.2. Safe and economical alternative to animal testing
5.1.4. Challenges
5.1.4.1. Complexity associated with the biological system
5.2. Market Trends
5.3. Cumulative Impact of COVID-19
5.4. Cumulative Impact of Russia-Ukraine Conflict
5.5. Cumulative Impact of High Inflation
5.6. Porter’s Five Forces Analysis
5.6.1. Threat of New Entrants
5.6.2. Threat of Substitutes
5.6.3. Bargaining Power of Customers
5.6.4. Bargaining Power of Suppliers
5.6.5. Industry Rivalry
5.7. Value Chain & Critical Path Analysis
5.8. Regulatory Framework
5.9. Client Customization
5.9.1. Technology Advancements
5.9.2. Impact Analysis

6. Biochips Market, by Type

6.1. Introduction
6.2. Arrays
6.2.1. Cell Arrays
6.2.2. Tissue Arrays
6.3. DNA Chips
6.4. Lab-On-A-Chip
6.5. Protein Chips

7. Biochips Market, by Fabrication Technology

7.1. Introduction
7.2. Microarrays
7.3. Microfluidics

8. Biochips Market, by Application

8.1. Introduction
8.2. Agricultural Biotechnology
8.3. Cancer Diagnosis & Treatment
8.4. Clinical Diagnostics
8.5. Diagnostics
8.6. DNA Chip Applications
8.7. Drug Discovery
8.8. Expression Profiling
8.9. Gene Expression
8.10. Genomics
8.11. High-Throughput Screening
8.12. IVD & POC
8.13. Proteomics
8.14. SNP Genotyping

9. Biochips Market, by End-User

9.1. Introduction
9.2. Academic & Research Institutes
9.3. Biotechnology & Pharmaceutical Companies
9.4. Hospitals & Diagnostics Centers

10. Americas Biochips Market

10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Biochips Market

11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa Biochips Market

12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape

13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis, By Key Player
13.3. Market Share Analysis, By Key Player
13.4. Competitive Scenario

14. Company Usability Profiles

14.1. Abbott Laboratories
14.2. Agilent Technologies, Inc.
14.3. AYOXXA Biosystems GmbH
14.4. Bio-Rad Laboratories, Inc.
14.5. Cellix Ltd.
14.6. Diagnostic Biochips
14.7. F. Hoffmann-La Roche Ltd.
14.8. GE Healthcare
14.9. Illumina, Inc.
14.10. Innovative Biochips
14.11. Luminex Corporation by DiaSorin S.p.A.
14.12. Merck KGaA
14.13. PerkinElmer Inc.
14.14. Sphere Fluidics Limited
14.15. Thermo Fisher Scientific Inc.

15. Appendix

15.1. Discussion Guide
15.2. License & Pricing

List of Figures

FIGURE 1. BIOCHIPS MARKET RESEARCH PROCESS
FIGURE 2. BIOCHIPS MARKET SIZE, 2022 VS 2030
FIGURE 3. BIOCHIPS MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 4. BIOCHIPS MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
FIGURE 5. BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2022 VS 2030 (%)
FIGURE 6. BIOCHIPS MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
FIGURE 7. BIOCHIPS MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
FIGURE 8. BIOCHIPS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 9. BIOCHIPS MARKET DYNAMICS
FIGURE 10. BIOCHIPS MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD BILLION)
FIGURE 11. BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2022 VS 2023 VS 2030 (USD BILLION)
FIGURE 12. BIOCHIPS MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD BILLION)
FIGURE 13. BIOCHIPS MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD BILLION)
FIGURE 14. AMERICAS BIOCHIPS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD BILLION)
FIGURE 15. UNITED STATES BIOCHIPS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD BILLION)
FIGURE 16. ASIA-PACIFIC BIOCHIPS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD BILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA BIOCHIPS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD BILLION)
FIGURE 18. BIOCHIPS MARKET, FPNV POSITIONING MATRIX, 2022
FIGURE 19. BIOCHIPS MARKET SHARE, BY KEY PLAYER, 2022

List of Tables

TABLE 1. BIOCHIPS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. BIOCHIPS MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 4. BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD BILLION)
TABLE 5. BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD BILLION)
TABLE 6. BIOCHIPS MARKET SIZE, BY ARRAYS, BY REGION, 2018-2030 (USD BILLION)
TABLE 7. BIOCHIPS MARKET SIZE, BY CELL ARRAYS, BY REGION, 2018-2030 (USD BILLION)
TABLE 8. BIOCHIPS MARKET SIZE, BY TISSUE ARRAYS, BY REGION, 2018-2030 (USD BILLION)
TABLE 9. BIOCHIPS MARKET SIZE, BY DNA CHIPS, BY REGION, 2018-2030 (USD BILLION)
TABLE 10. BIOCHIPS MARKET SIZE, BY LAB-ON-A-CHIP, BY REGION, 2018-2030 (USD BILLION)
TABLE 11. BIOCHIPS MARKET SIZE, BY PROTEIN CHIPS, BY REGION, 2018-2030 (USD BILLION)
TABLE 12. BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD BILLION)
TABLE 13. BIOCHIPS MARKET SIZE, BY MICROARRAYS, BY REGION, 2018-2030 (USD BILLION)
TABLE 14. BIOCHIPS MARKET SIZE, BY MICROFLUIDICS, BY REGION, 2018-2030 (USD BILLION)
TABLE 15. BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 16. BIOCHIPS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, BY REGION, 2018-2030 (USD BILLION)
TABLE 17. BIOCHIPS MARKET SIZE, BY CANCER DIAGNOSIS & TREATMENT, BY REGION, 2018-2030 (USD BILLION)
TABLE 18. BIOCHIPS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2030 (USD BILLION)
TABLE 19. BIOCHIPS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD BILLION)
TABLE 20. BIOCHIPS MARKET SIZE, BY DNA CHIP APPLICATIONS, BY REGION, 2018-2030 (USD BILLION)
TABLE 21. BIOCHIPS MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD BILLION)
TABLE 22. BIOCHIPS MARKET SIZE, BY EXPRESSION PROFILING, BY REGION, 2018-2030 (USD BILLION)
TABLE 23. BIOCHIPS MARKET SIZE, BY GENE EXPRESSION, BY REGION, 2018-2030 (USD BILLION)
TABLE 24. BIOCHIPS MARKET SIZE, BY GENOMICS, BY REGION, 2018-2030 (USD BILLION)
TABLE 25. BIOCHIPS MARKET SIZE, BY HIGH-THROUGHPUT SCREENING, BY REGION, 2018-2030 (USD BILLION)
TABLE 26. BIOCHIPS MARKET SIZE, BY IVD & POC, BY REGION, 2018-2030 (USD BILLION)
TABLE 27. BIOCHIPS MARKET SIZE, BY PROTEOMICS, BY REGION, 2018-2030 (USD BILLION)
TABLE 28. BIOCHIPS MARKET SIZE, BY SNP GENOTYPING, BY REGION, 2018-2030 (USD BILLION)
TABLE 29. BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 30. BIOCHIPS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD BILLION)
TABLE 31. BIOCHIPS MARKET SIZE, BY BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD BILLION)
TABLE 32. BIOCHIPS MARKET SIZE, BY HOSPITALS & DIAGNOSTICS CENTERS, BY REGION, 2018-2030 (USD BILLION)
TABLE 33. AMERICAS BIOCHIPS MARKET SIZE, BY COUNTRY, 2018-2030 (USD BILLION)
TABLE 34. AMERICAS BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD BILLION)
TABLE 35. AMERICAS BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD BILLION)
TABLE 36. AMERICAS BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD BILLION)
TABLE 37. AMERICAS BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 38. AMERICAS BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 39. ARGENTINA BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD BILLION)
TABLE 40. ARGENTINA BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD BILLION)
TABLE 41. ARGENTINA BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD BILLION)
TABLE 42. ARGENTINA BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 43. ARGENTINA BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 44. BRAZIL BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD BILLION)
TABLE 45. BRAZIL BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD BILLION)
TABLE 46. BRAZIL BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD BILLION)
TABLE 47. BRAZIL BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 48. BRAZIL BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 49. CANADA BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD BILLION)
TABLE 50. CANADA BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD BILLION)
TABLE 51. CANADA BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD BILLION)
TABLE 52. CANADA BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 53. CANADA BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 54. MEXICO BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD BILLION)
TABLE 55. MEXICO BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD BILLION)
TABLE 56. MEXICO BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD BILLION)
TABLE 57. MEXICO BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 58. MEXICO BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 59. UNITED STATES BIOCHIPS MARKET SIZE, BY STATE, 2018-2030 (USD BILLION)
TABLE 60. UNITED STATES BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD BILLION)
TABLE 61. UNITED STATES BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD BILLION)
TABLE 62. UNITED STATES BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD BILLION)
TABLE 63. UNITED STATES BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 64. UNITED STATES BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 65. ASIA-PACIFIC BIOCHIPS MARKET SIZE, BY COUNTRY, 2018-2030 (USD BILLION)
TABLE 66. ASIA-PACIFIC BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD BILLION)
TABLE 67. ASIA-PACIFIC BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD BILLION)
TABLE 68. ASIA-PACIFIC BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD BILLION)
TABLE 69. ASIA-PACIFIC BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 70. ASIA-PACIFIC BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 71. AUSTRALIA BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD BILLION)
TABLE 72. AUSTRALIA BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD BILLION)
TABLE 73. AUSTRALIA BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD BILLION)
TABLE 74. AUSTRALIA BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 75. AUSTRALIA BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 76. CHINA BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD BILLION)
TABLE 77. CHINA BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD BILLION)
TABLE 78. CHINA BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD BILLION)
TABLE 79. CHINA BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 80. CHINA BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 81. INDIA BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD BILLION)
TABLE 82. INDIA BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD BILLION)
TABLE 83. INDIA BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD BILLION)
TABLE 84. INDIA BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 85. INDIA BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 86. INDONESIA BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD BILLION)
TABLE 87. INDONESIA BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD BILLION)
TABLE 88. INDONESIA BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD BILLION)
TABLE 89. INDONESIA BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 90. INDONESIA BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 91. JAPAN BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD BILLION)
TABLE 92. JAPAN BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD BILLION)
TABLE 93. JAPAN BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD BILLION)
TABLE 94. JAPAN BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 95. JAPAN BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 96. MALAYSIA BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD BILLION)
TABLE 97. MALAYSIA BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD BILLION)
TABLE 98. MALAYSIA BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD BILLION)
TABLE 99. MALAYSIA BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 100. MALAYSIA BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 101. PHILIPPINES BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD BILLION)
TABLE 102. PHILIPPINES BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD BILLION)
TABLE 103. PHILIPPINES BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD BILLION)
TABLE 104. PHILIPPINES BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 105. PHILIPPINES BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 106. SINGAPORE BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD BILLION)
TABLE 107. SINGAPORE BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD BILLION)
TABLE 108. SINGAPORE BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD BILLION)
TABLE 109. SINGAPORE BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 110. SINGAPORE BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 111. SOUTH KOREA BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD BILLION)
TABLE 112. SOUTH KOREA BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD BILLION)
TABLE 113. SOUTH KOREA BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD BILLION)
TABLE 114. SOUTH KOREA BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 115. SOUTH KOREA BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 116. TAIWAN BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD BILLION)
TABLE 117. TAIWAN BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD BILLION)
TABLE 118. TAIWAN BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD BILLION)
TABLE 119. TAIWAN BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 120. TAIWAN BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 121. THAILAND BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD BILLION)
TABLE 122. THAILAND BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD BILLION)
TABLE 123. THAILAND BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD BILLION)
TABLE 124. THAILAND BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 125. THAILAND BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 126. VIETNAM BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD BILLION)
TABLE 127. VIETNAM BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD BILLION)
TABLE 128. VIETNAM BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD BILLION)
TABLE 129. VIETNAM BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 130. VIETNAM BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA BIOCHIPS MARKET SIZE, BY COUNTRY, 2018-2030 (USD BILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD BILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD BILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD BILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 137. DENMARK BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD BILLION)
TABLE 138. DENMARK BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD BILLION)
TABLE 139. DENMARK BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD BILLION)
TABLE 140. DENMARK BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 141. DENMARK BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 142. EGYPT BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD BILLION)
TABLE 143. EGYPT BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD BILLION)
TABLE 144. EGYPT BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD BILLION)
TABLE 145. EGYPT BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 146. EGYPT BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 147. FINLAND BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD BILLION)
TABLE 148. FINLAND BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD BILLION)
TABLE 149. FINLAND BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD BILLION)
TABLE 150. FINLAND BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 151. FINLAND BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 152. FRANCE BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD BILLION)
TABLE 153. FRANCE BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD BILLION)
TABLE 154. FRANCE BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD BILLION)
TABLE 155. FRANCE BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 156. FRANCE BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 157. GERMANY BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD BILLION)
TABLE 158. GERMANY BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD BILLION)
TABLE 159. GERMANY BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD BILLION)
TABLE 160. GERMANY BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 161. GERMANY BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 162. ISRAEL BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD BILLION)
TABLE 163. ISRAEL BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD BILLION)
TABLE 164. ISRAEL BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD BILLION)
TABLE 165. ISRAEL BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 166. ISRAEL BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 167. ITALY BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD BILLION)
TABLE 168. ITALY BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD BILLION)
TABLE 169. ITALY BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD BILLION)
TABLE 170. ITALY BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 171. ITALY BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 172. NETHERLANDS BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD BILLION)
TABLE 173. NETHERLANDS BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD BILLION)
TABLE 174. NETHERLANDS BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD BILLION)
TABLE 175. NETHERLANDS BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 176. NETHERLANDS BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 177. NIGERIA BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD BILLION)
TABLE 178. NIGERIA BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD BILLION)
TABLE 179. NIGERIA BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD BILLION)
TABLE 180. NIGERIA BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 181. NIGERIA BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 182. NORWAY BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD BILLION)
TABLE 183. NORWAY BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD BILLION)
TABLE 184. NORWAY BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD BILLION)
TABLE 185. NORWAY BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 186. NORWAY BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 187. POLAND BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD BILLION)
TABLE 188. POLAND BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD BILLION)
TABLE 189. POLAND BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD BILLION)
TABLE 190. POLAND BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 191. POLAND BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 192. QATAR BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD BILLION)
TABLE 193. QATAR BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD BILLION)
TABLE 194. QATAR BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD BILLION)
TABLE 195. QATAR BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 196. QATAR BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 197. RUSSIA BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD BILLION)
TABLE 198. RUSSIA BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD BILLION)
TABLE 199. RUSSIA BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD BILLION)
TABLE 200. RUSSIA BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 201. RUSSIA BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 202. SAUDI ARABIA BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD BILLION)
TABLE 203. SAUDI ARABIA BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD BILLION)
TABLE 204. SAUDI ARABIA BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD BILLION)
TABLE 205. SAUDI ARABIA BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 206. SAUDI ARABIA BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 207. SOUTH AFRICA BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD BILLION)
TABLE 208. SOUTH AFRICA BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD BILLION)
TABLE 209. SOUTH AFRICA BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD BILLION)
TABLE 210. SOUTH AFRICA BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 211. SOUTH AFRICA BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 212. SPAIN BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD BILLION)
TABLE 213. SPAIN BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD BILLION)
TABLE 214. SPAIN BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD BILLION)
TABLE 215. SPAIN BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 216. SPAIN BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 217. SWEDEN BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD BILLION)
TABLE 218. SWEDEN BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD BILLION)
TABLE 219. SWEDEN BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD BILLION)
TABLE 220. SWEDEN BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 221. SWEDEN BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 222. SWITZERLAND BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD BILLION)
TABLE 223. SWITZERLAND BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD BILLION)
TABLE 224. SWITZERLAND BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD BILLION)
TABLE 225. SWITZERLAND BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 226. SWITZERLAND BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 227. TURKEY BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD BILLION)
TABLE 228. TURKEY BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD BILLION)
TABLE 229. TURKEY BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD BILLION)
TABLE 230. TURKEY BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 231. TURKEY BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 232. UNITED ARAB EMIRATES BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD BILLION)
TABLE 233. UNITED ARAB EMIRATES BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD BILLION)
TABLE 234. UNITED ARAB EMIRATES BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD BILLION)
TABLE 235. UNITED ARAB EMIRATES BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 236. UNITED ARAB EMIRATES BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 237. UNITED KINGDOM BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD BILLION)
TABLE 238. UNITED KINGDOM BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD BILLION)
TABLE 239. UNITED KINGDOM BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD BILLION)
TABLE 240. UNITED KINGDOM BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 241. UNITED KINGDOM BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 242. BIOCHIPS MARKET, FPNV POSITIONING MATRIX, SCORES, 2022
TABLE 243. BIOCHIPS MARKET, FPNV POSITIONING MATRIX, BUSINESS STRATEGY, 2022
TABLE 244. BIOCHIPS MARKET, FPNV POSITIONING MATRIX, PRODUCT SATISFACTION, 2022
TABLE 245. BIOCHIPS MARKET RANKING, BY KEY PLAYER, 2022
TABLE 246. BIOCHIPS MARKET SHARE, BY KEY PLAYER, 2022
TABLE 247. BIOCHIPS MARKET LICENSE & PRICING